Autism Spectrum Disorder Trial, Recruiting (NCT06158581)

Autism Spectrum Disorder Trial, Recruiting NCT06158581 Sponsor: University of Pittsburgh Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06158581 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have received a formal diagnosis of Autism Spectrum Disorder (ASD) from a professional
People whose scores on a specific emotional assessment tool (called the EDI) fall within the clinical range for either emotional reactivity or feelings of sadness/low mood, based on responses from themselves or a caregiver
People who are able to give their own consent to participate and answer questions about themselves
People who have at least one support person (such as a parent, caregiver, family member, partner, or friend) who can also answer questions about them — though independent adults may be able to opt out of this part
People who currently live in Alabama or Pennsylvania

Who may not be able to join:

People who are currently at immediate risk of harming themselves or others (such as an imminent threat of suicide or homicide)
People who are currently experiencing acute psychosis (a serious break from reality) or mania (an extreme high-energy or elevated mood episode)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carla Mazefsky, PhD, University of Pittsburgh

Phone: 1-866-647-3436

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06158581

Sponsor: University of Pittsburgh

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 1-866-647-3436

More information: https://clinicaltrials.gov/study/NCT06158581

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have received a formal diagnosis of Autism Spectrum Disorder (ASD) from a professional
People whose scores on a specific emotional assessment tool (called the EDI) fall within the clinical range for either emotional reactivity or feelings of sadness/low mood, based on responses from themselves or a caregiver
People who are able to give their own consent to participate and answer questions about themselves
People who have at least one support person (such as a parent, caregiver, family member, partner, or friend) who can also answer questions about them — though independent adults may be able to opt out of this part
People who currently live in Alabama or Pennsylvania

Who may not be able to join:

People who are currently at immediate risk of harming themselves or others (such as an imminent threat of suicide or homicide)
People who are currently experiencing acute psychosis (a serious break from reality) or mania (an extreme high-energy or elevated mood episode)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Pittsburgh

Registry

ClinicalTrials.gov

Start date

8 April 2024

Est. completion

1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Emotion Dysregulation Inventory; Weiner's Acceptability, Appropriateness, & Feasibility of Intervention Scales; Provider Self-Efficacy Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov